The weekly litigation news digest is live. Subscribe now

IP Verse

Inhibitors Of Bruton'S Tyrosine Kinase - EP2529622

The patent EP2529622 was granted to Pharmacyclics on Jan 17, 2018. The application was originally filed on Dec 28, 2006 under application number EP12166302A. The patent is currently recorded with a legal status of "Revoked".

EP2529622

PHARMACYCLICS
Application Number
EP12166302A
Filing Date
Dec 28, 2006
Status
Revoked
May 24, 2019
Publication Date
Jan 17, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Compounds that inhibit Bruton's tyrosine kinase (Btk) for treating diseases like autoimmune disorders, inflammatory conditions, and cancers. The compounds are irreversible inhibitors that form a covalent bond with a cysteine residue in Btk. They have structures with a 1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl) prop-2-en-1-one core.

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

GENERICS UKOct 17, 2018TER MEER STEINMEISTER & PARTNERADMISSIBLE

Patent Citations (75) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2004013734
DESCRIPTIONUS3598122
DESCRIPTIONUS3598123
DESCRIPTIONUS3710795
DESCRIPTIONUS3731683
DESCRIPTIONUS3742951
DESCRIPTIONUS3814097
DESCRIPTIONUS3921636
DESCRIPTIONUS3972995
DESCRIPTIONUS3993072
DESCRIPTIONUS3993073
DESCRIPTIONUS3996934
DESCRIPTIONUS4031894
DESCRIPTIONUS4060084
DESCRIPTIONUS4069307
DESCRIPTIONUS4077407
DESCRIPTIONUS4151273
DESCRIPTIONUS4201211
DESCRIPTIONUS4229447
DESCRIPTIONUS4230105
DESCRIPTIONUS4292299
DESCRIPTIONUS4292303
DESCRIPTIONUS4327725
DESCRIPTIONUS4343789
DESCRIPTIONUS4476116
DESCRIPTIONUS4596795
DESCRIPTIONUS4624848
DESCRIPTIONUS4755386
DESCRIPTIONUS4871549
DESCRIPTIONUS4968509
DESCRIPTIONUS5011692
DESCRIPTIONUS5017381
DESCRIPTIONUS5033252
DESCRIPTIONUS5052558
DESCRIPTIONUS5116817
DESCRIPTIONUS5229135
DESCRIPTIONUS5260068
DESCRIPTIONUS5260069
DESCRIPTIONUS5281420
DESCRIPTIONUS5323907
DESCRIPTIONUS5336168
DESCRIPTIONUS5340591
DESCRIPTIONUS5456923
DESCRIPTIONUS5461140
DESCRIPTIONUS5508040
DESCRIPTIONUS5516527
DESCRIPTIONUS5567441
DESCRIPTIONUS5622721
DESCRIPTIONUS5665378
DESCRIPTIONUS5686105
DESCRIPTIONUS5700410
DESCRIPTIONUS5700485
DESCRIPTIONUS5723269
DESCRIPTIONUS5739136
DESCRIPTIONUS5837280
DESCRIPTIONUS5837284
DESCRIPTIONUS5840329
DESCRIPTIONUS5858401
DESCRIPTIONUS5869090
DESCRIPTIONUS5977175
DESCRIPTIONUS6083518
DESCRIPTIONUS6326469
DESCRIPTIONUS6391452
DESCRIPTIONUS6465014
DESCRIPTIONUS6667048
DESCRIPTIONUS6923983
DESCRIPTIONUS6929801
DESCRIPTIONUS6932983
DESCRIPTIONUS6946144
DESCRIPTIONUS6960563
DESCRIPTIONWO0119829
OPPOSITIONUS5530012
OPPOSITIONWO0119829
OPPOSITIONWO02076986
SEARCHWO02076986

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents